Emergent BioSolutions
CBRN Defense · Public Health & Prevention

Emergent BioSolutions revenue, results and funding

Emergent BioSolutions filed revenue of $742.9M for 2025.

Data updated Nov 17, 2026 · Back to the company report
$742.9MRevenue, 2025
$52.6MNet income, 2025
$47.9MTotal raised

Results by year

YearRevenueNet incomeTotal assets
2025$742.9M$52.6M$1.3B
2024$1B−$190.6M$1.4B
2023$1B−$760.5M$1.8B
2022$1.1B−$211.6M$3.2B
2021$1.8B$219.5M$3B
2020$1.6B$305.8M$2.9B
2019$1.1B$54.5M$2.3B
2018$782.4M$62.7M$2.2B
2017$560.9M$82.6M$1.1B
2016$488.8M$51.8M$970.1M
2015$522.8M$62.9M$1B
2014$450.1M$36.7M$938.7M
2013$312.7M$31.1M$626.6M
2012$281.9M$23.5M$564.2M
2011$273.4M$23M$546.9M
Sources: SEC

Rounds and grants

YearRoundAmount
2018Venture$47.9M
Sources: funding announcements, SEC filings, grant registers

How to cite

Emergent BioSolutions, Financials. Alion, Nov 17, 2026. https://alion.io/company/emergentbiosolutions/financials

.json · .md · CC BY-SA 4.0